By monitoring the activity of AKT protein kinase as a readout for FRα-mediated drug delivery by 3WJ nanoparticles, we confirmed that PI-103 remains fully functional and stable over the course of receptor-targeted small molecule drug delivery to cancer cells. Here, AKT1 is linked to cancer.